Early Child Development and Nutrition in Guatemala
Primary Purpose
Undernutrition
Status
Completed
Phase
Not Applicable
Locations
Guatemala
Study Type
Interventional
Intervention
Micronutrients
Responsive feeding
Placebo
Sponsored by
About this trial
This is an interventional treatment trial for Undernutrition focused on measuring Micronutrient intervention, Responsive feeding intervention, School readiness intervention
Eligibility Criteria
Inclusion Criteria:
- Child speaks Spanish.
- Child is age 6-12 months or age 36-48 months.
- Child must be undernourished (length and height for age < -1 z-score).
- Child does not have any obvious health or developmental problems that would interfere with growth, nutrition, or development.
- Child will remain in the area for the subsequent year.
- Parent or legal guardian of the child is age 18 years or older.
- Parent or legal guardian speaks and understands Spanish.
- Parent or legal guardian lives with child in study community.
Exclusion Criteria:
- Child is not age 6-12 months or 36-48 months.
- Child has severe stunting (length and height for age < -3 z-scores).
- Child has identified conditions that could interfere with their development and growth.
- Child is severely anemic (hemoglobin < 7).
Sites / Locations
- APEVIHS (Association for the Prevention and Study of HIV/AIDS)
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Experimental
Placebo Comparator
Experimental
Placebo Comparator
Arm Label
Micronutrients No responsive feeding
Placebo and Responsive Feeding
Micronutrients and Responsive caregiving
Placebo and No responsive caregiving
Arm Description
Micronutrient powder and no responsive feeding
Placebo (vitamin B2) and Responsive Feeding
Micronutrients and Responsive feeding intervention
Placebo and No responsive caregiving
Outcomes
Primary Outcome Measures
Change in cognitive, motor, social-emotional development from baseline to 12 months
Cognitive and social-emotional assessments
Secondary Outcome Measures
Change in Growth from baseline to 12 months
Weight, length/height
Change in micronutrient status from baseline to 12 months
Blood draw
Full Information
NCT ID
NCT02302729
First Posted
October 31, 2014
Last Updated
August 14, 2019
Sponsor
University of Maryland, Baltimore
Collaborators
Association for the Study and Prevention of HIV/AIDS
1. Study Identification
Unique Protocol Identification Number
NCT02302729
Brief Title
Early Child Development and Nutrition in Guatemala
Official Title
Professor, Department of Pediatrics, University of Maryland School of Medicine
Study Type
Interventional
2. Study Status
Record Verification Date
August 2019
Overall Recruitment Status
Completed
Study Start Date
February 16, 2015 (Actual)
Primary Completion Date
December 8, 2015 (Actual)
Study Completion Date
December 8, 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Maryland, Baltimore
Collaborators
Association for the Study and Prevention of HIV/AIDS
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Over 200 million children under the age of 5 years in low and middle-income countries do not reach their developmental potential, largely due to lack of adequate nutrients and lack of psychosocial stimulation. Stunting (length-for-age < -2 z-scores) is an indication of chronic undernutrition. Guatemala has the high rates of stunting in the Western Hemisphere (over 40%). This trial examines the effect of providing a micronutrient powder manufactured in Guatemala vs. placebo and an early learning environment vs. no early learning environment on the growth, health, and development of young children in Guatemala.
Detailed Description
The plan is to implement a clustered randomized placebo controlled trial with an infant phase (6-12 months of age) and a preschool phase (36-48 months of age). For the infant phase, the investigators will use ProPAN (Process for the Promotion of Child Feeding) in the development of the evaluation and intervention, with modifications as necessary for the Guatemalan context. ProPAN is a tool developed and distributed by the Pan American Health Organization to develop, implement, and evaluate interventions and programs to improve infant and young child diet and feeding. ProPAN includes four modules:
Module 1: Assessment Module 2: Testing Recipes and Recommendations Module 3: Intervention Module 4: Monitoring and Evaluation
For the preschool phase, the investigators will use an evidence-based school readiness intervention (Little By Little) that has been shown to be effective with Hispanic preschoolers. The intervention will be implemented through the Association for the Prevention and Study of HIV/AIDS who will train and supervise the community health workers. By working directly with a local non-profit organization, the project will be well positioned to inform strategies to scale up the intervention on a community wide basis, if beneficial effects are shown.
The project examines the effects of an integrated intervention that includes both micronutrient powder added to food and responsive feeding for infants or school readiness for preschoolers. The primary aim is to examine how an integrated micronutrients + responsive feeding/school readiness intervention changes the development (primary outcome), growth and micronutrient status (secondary outcomes) of young children. The investigators will focus on infants (6-12 months) when the risk for micronutrient deficiencies is high, as they transition from breast feeding to complementary feeding and the family diet. The investigators will focus on preschoolers (36-48 months) to examine if micronutrients + a school readiness intervention can improve children's school readiness skills. The design includes neighborhood clusters randomized into four groups: 1) micronutrients plus responsive feeding/school readiness 2) micronutrients only, 3) placebo plus responsive feeding/school readiness, and 4) placebo only.
The investigators will test the following hypotheses:
Children in the two micronutrients groups have better change from baseline in development (primary outcome), growth and micronutrient status (secondary oitcomes), than children in the two placebo groups.
Mothers and children in the two responsive feeding/school readiness groups have better change from baseline measures of child development than those in the two control groups.
The impact of the responsive feeding/school readiness intervention is greater in the micronutrient groups than in the placebo groups. Children in the micronutrients plus responsive feeding/school readiness group have better change from baseline in development than children in any of the other three groups.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Undernutrition
Keywords
Micronutrient intervention, Responsive feeding intervention, School readiness intervention
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
1730 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Micronutrients No responsive feeding
Arm Type
Experimental
Arm Description
Micronutrient powder and no responsive feeding
Arm Title
Placebo and Responsive Feeding
Arm Type
Placebo Comparator
Arm Description
Placebo (vitamin B2) and Responsive Feeding
Arm Title
Micronutrients and Responsive caregiving
Arm Type
Experimental
Arm Description
Micronutrients and Responsive feeding intervention
Arm Title
Placebo and No responsive caregiving
Arm Type
Placebo Comparator
Arm Description
Placebo and No responsive caregiving
Intervention Type
Dietary Supplement
Intervention Name(s)
Micronutrients
Intervention Description
Nutrient Quantity Nutrient Quantity Zinc 9 mg Copper 0.3 mg Iron 12.5 mg Vitamin D3 5 mg Folic Acid 160 mcg Vitamin E 5 mg Iodine 90 mcg Calcium 200 mg Vitamin A 250 mg Phosphorus 150 mg Vitamin C 40 mg Magnesium 40 mg Vitamin B12 0.9 mcg Selenium 17 mcg Thiamine 0.5 mg Manganese 0.17 mg Niacin 0.5 mg Biotin 8 mg Riboflavin 6 mg Vitamin B5 1.8 mg Vitamin B6 0.5 mg
Intervention Type
Behavioral
Intervention Name(s)
Responsive feeding
Intervention Description
Strategy
Mother ensures that feeding area is set up with infant and mother able to see one another.
Mother mirrors the infant's facial expressions to attract the infant's attention.
Mother interprets infant's behavior with a positive voice, "Oh, you like the spinach." Mother extends infant's behavior by saying, "Oh the cereal is all gone" and doing a consistent hand signal Mother models eating, makes positive comments in a nurturing tone. Mother offers finger food or use of utensil
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Riboflavin Vitamin B2
Primary Outcome Measure Information:
Title
Change in cognitive, motor, social-emotional development from baseline to 12 months
Description
Cognitive and social-emotional assessments
Time Frame
Baseline, 12 months
Secondary Outcome Measure Information:
Title
Change in Growth from baseline to 12 months
Description
Weight, length/height
Time Frame
Baseline, 12 months
Title
Change in micronutrient status from baseline to 12 months
Description
Blood draw
Time Frame
Baseline, 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
4 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Child speaks Spanish.
Child is age 6-12 months or age 36-48 months.
Child must be undernourished (length and height for age < -1 z-score).
Child does not have any obvious health or developmental problems that would interfere with growth, nutrition, or development.
Child will remain in the area for the subsequent year.
Parent or legal guardian of the child is age 18 years or older.
Parent or legal guardian speaks and understands Spanish.
Parent or legal guardian lives with child in study community.
Exclusion Criteria:
Child is not age 6-12 months or 36-48 months.
Child has severe stunting (length and height for age < -3 z-scores).
Child has identified conditions that could interfere with their development and growth.
Child is severely anemic (hemoglobin < 7).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Maureen M Black, Ph.D.
Organizational Affiliation
Uniersity of Maryland, Baltimore
Official's Role
Principal Investigator
Facility Information:
Facility Name
APEVIHS (Association for the Prevention and Study of HIV/AIDS)
City
Retalhuleu
Country
Guatemala
12. IPD Sharing Statement
Citations:
Citation
Unable to connect to PubMed to validate , last attempt on November 19, 2014 at 3:47 PM EST
Results Reference
background
Learn more about this trial
Early Child Development and Nutrition in Guatemala
We'll reach out to this number within 24 hrs